240例上消化道黏膜下肿瘤内镜治疗的疗效及并发症评估

doi:10.6040/j.issn.1671-7554.0.2020.1446

摘要/Abstract

摘要： 目的探究上消化道黏膜下肿瘤(SMT)患者的临床特点及影响SMT患者术后并发症及住院花费的临床因素。方法收集2012年1月至2019年6月于山东大学附属山东省立医院就诊的240例SMT患者的临床资料,统计分析入组SMT患者的临床特点、病理类型、治疗方案及治疗效果。结果本研究共入组240例SMT患者,其中男性101例(42.1%),女性139例(57.9%);平均发病年龄为54.19岁; 通过超声胃镜确定SMT大小、部位及起源, 食管57例(23.8%)、胃食管结合部位 7例(7.1%)、胃163例(67.9%)、十二指肠3例(1.3%),SMT平均大小为1.12 cm,153例(71.5%)起源于固有肌层,37例(17.7%)起源于黏膜肌层,24例(11.2%)起源于黏膜下层; 69例(28.8%)患者给予内镜黏膜下剥离术(ESD)治疗,117例(48.8%)患者给予内镜黏膜下挖除术(ESE),28例(11.7%)患者给予内镜全层切除术(EFR),26例(10.7%)患者给予经黏膜下隧道内镜肿瘤切除术(STER);病理类型以平滑肌瘤(117,49.2%)和间质瘤(78,32.8%)为主。237例(98.8%)患者于内镜下成功治疗,整块切除率达到90.4%(217/240)。患者的平均手术时间为58.37 min,平均住院10.07 d,平均住院花费35 830.3元。术后共有17例(7.1%)患者出现并发症,其中10例(4.2%)患者给予保守治疗后症状缓解,7例(2.9%)患者给予积极干预后缓解,无死亡或远期并发症病例。手术时长≥55 min、SMT≥2 cm为SMT患者术后发生并发症的高危因素,手术时间≥55 min、SMT≥2 cm、未能整块切除及使用内镜吻合夹系统OTSC是住院花费的正性影响因素。结论内镜下切除是治疗SMT安全有效的方式,早期发现、早期治疗、缩短手术时间是降低SMT患者术后并发症发生率及减少患者住院花费的有效途径。

关键词: 黏膜下肿瘤, 消化内镜, 临床特点, 疗效, 并发症

Abstract: Objective To explore the clinical characteristics of upper gastrointestinal submucosal tumors(SMT)and clinical factors affecting postoperative complications and hospitalization costs of SMT patients. Methods The clinical data of 240 SMT patients treated in Shandong Provincial Hospital during Jan. 2012 and Jun. 2019 were collected, and the clinical characteristics, pathological types, treatment modalities and therapeutic effects were analyzed. Results The patients included 101 male(42.1%)and 139 female(57.9%), mean age 54.19 years, and mean size of SMT 1.12 cm. The tumors were located in the esophagus in 57 cases(23.8%), in the gastroesophageal junction in 17 cases(7.1%), in the stomach in 163 cases(67.9%), and in the duodenum in 3 cases(1.3%). Endoscopic submucosal dissection(ESD)was performed in 69 patients(28.8%), endoscopic submucosal excavation(ESE)in 117 patients(48.8%), endoscopic full-thickness resection(EFR)in 28 patients(11.7%), and submucosal tunneling endoscopic resection(STER)in 26 patients(10.7%). The main pathological types were leiomyoma(117, 49.2%)and stromal tumor(78, 32.8%). Altogether 237 patients(98.8%)were successfully treated, with 90.4%(217/240)en bloc resection rate. The mean operation time was 58.37 minutes, hospital stay 10.07 days, and hospitalization costs 35 830.3 yuan. Complications were observed in 17 patients(7.1%), 10(4.2%)of whom relieved after conservative treatment and 7(2.9%)received active interventions such as endoscopic hemostasis, gastrointestinal decompression and puncture drainage. No death or long-term complications occurred. Operation time ≥55 min and SMT≥2 cm were the risk factors of postoperative complications; meanwhile, operation time ≥55 min, SMT≥2 cm, failure of en bloc resection and use of OTSC increased hospitalization costs. Conclusion Endoscopic resection is a safe and effective treatment modality of SMT. Early detection, early treatment and short operation time are effective ways to reduce the incidence of postoperative complications and hospitalization costs.

Key words: Submucosal tumors, Endoscope, Clinical characteristics, Efficacy, Complications

中图分类号:

R735

罗应舒,李宾,许昌芹,姜军梅,许洪伟. 240例上消化道黏膜下肿瘤内镜治疗的疗效及并发症评估[J]. 山东大学学报 (医学版), 2021, 59(3): 74-80.

LUO Yingshu, LI Bin, XU Changqin, JIANG Junmei, XU Hongwei. Evaluation of the efficacy and complications of endoscopic treatment of 240 cases of upper gastrointestinal submucosal tumors[J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 74-80.

参考文献

[1] Nishida T, Kawai N, Yamaguchi S, et al. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors [J]. Dig Endosc, 2013, 25(5): 479-489.
[2] Papanikolaou IS, Triantafyllou K, Kourikou A, et al. Endoscopic ultrasonography for gastric submucosal lesions [J]. World J Gastrointest Endosc, 2011, 3(5): 86-94.
[3] Longcroft-Wheaton G, Bhandari P. Endoscopic resection of submucosal tumors [J]. Expert Rev Gastroenterol Hepatol, 2015, 9(5): 659-669.
[4] Polkowski M. Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors [J]. Endoscopy, 2005, 37(7): 635-645.
[5] Nishida T, Goto O, Raut C P, et al. Diagnostic and treatment strategy for small gastrointestinal stromal tumors [J]. Cancer, 2016, 122(20): 3110-3118.
[6] Abe N, Takeuchi H, Ohki A, et al. Comparison between endoscopic and laparoscopic removal of gastric submucosal tumor [J]. Dig Endosc, 2018, Suppl 1:7-16. doi: 10.1111/den.13010.
[7] Chai N, Du C, Gao Y, et al. Comparison between submucosal tunneling endoscopic resection and video-assisted thoracoscopic enucleation for esophageal submucosal tumors originating from the muscularis propria layer: a randomized controlled trial [J]. Surg Endosc, 2018, 32(7): 3364-3372.
[8] Kikuchi S, Nishizaki M, Kuroda S, et al. Nonexposure laparoscopic and endoscopic cooperative surgery(closed laparoscopic and endoscopic cooperative surgery)for gastric submucosal tumor [J]. Gastric Cancer, 2017, 20(3): 553-557.
[9] Onimaru M, Inoue H, Bechara R, et al. Clinical outcomes of per-oral endoscopic tumor resection for submucosal tumors in the esophagus and gastric cardia [J]. Dig Endosc, 2020, 32(3): 328-336.
[10] Nabi Z, Ramchandani M, Chavan R, et al. Endoscopic dissection of an esophageal submucosal tumor using a novel bipolar radiofrequency device [J]. Endoscopy, 2020, 52(7): E257-E258.
[11] Standards of Practice C, Faulx AL, Kothari S, et al. The role of endoscopy in subepithelial lesions of the GI tract [J]. Gastrointest Endosc, 2017, 85(6): 1117-1132.
[12] 沈琳, 曹晖, 秦叔逵, 等. 中国胃肠间质瘤诊断治疗共识[J]. 肿瘤综合治疗电子杂志, 2018, 4(1): 31-43. SHEN Lin, CAO Hui, QIN Shuikui, et al. Chinese consensus on diagnosis and treatment of gastrointestinal stromal tumors [J]. Journal of Multidisciplinary Cancer Management, 2018, 4(1): 31-43.
[13] Zhou P, Zhong Y, Li Q. Chinese consensus on endoscopic diagnosis and management of gastrointestinal submucosal tumor(version 2018)[J]. Zhonghua Wei Chang Wai Ke Za ZHi, 2018, 21(8): 841-852.
[14] Li B, Chen T, Qi ZP, et al. Efficacy and safety of endoscopic resection for small submucosal tumors originating from the muscularis propria layer in the gastric fundus [J]. Surg Endosc, 2019, 33(8): 2553-2561.
[15] Joo MK, Park JJ, Kim H, et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract [J]. Gastrointest Endosc, 2016, 83(2): 318-326.
[16] Yang YT, Shen N, Ao F, et al. Diagnostic value of contrast-enhanced harmonic endoscopic ultrasonography in predicting the malignancy potential of submucosal tumors: a systematic review and meta-analysis [J]. Surg Endosc, 2020, 34(9): 3754-3765.
[17] 李琛, 谭玉勇, 乐梅先, 等. 内镜黏膜下剥离术治疗十二指肠病变的临床疗效分析[J]. 中华消化内镜杂志, 2010, 37(3): 190-4. LI Chen, TAN Yuyong, LE Meixian, et al. Efficacy of endoscopic submucosal dissection for duodenal lesions [J]. Chinese Journal of Digestive Endoscopy, 2010, 37(3): 190-194.
[18] Xiu H, Zhao CY, Liu FG, et al. Comparing about three types of endoscopic therapy methods for upper gastrointestinal submucosal tumors originating from the muscularis propria layer [J]. Scand J Gastroenterol, 2019, 54(12): 1481-1486.
[19] Cai MY, Martin Carreras-Presas F, Zhou PH. Endoscopic full-thickness resection for gastrointestinal submucosal tumors [J]. Dig Endosc, 2018(Suppl 1): 17-24. doi: 10.1111/den.13003.
[20] Xu HW, Zhao Q, Yu SX, et al. Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction [J]. BMC Gastroenterol, 2019, 19(1): 174.
[21] Du C, Chai N, Linghu E, et al. Treatment of cardial submucosal tumors originating from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation [J]. Surg Endosc, 2018, 32(11): 4543-4551.
[22] Lv XH, Wang CH, Xie Y. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors: a systematic review and meta-analysis [J]. Surg Endosc, 2017, 31(1): 49-63.
[23] Chen T, Zhang C, Yao LQ, et al. Management of the complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors [J]. Endoscopy, 2016, 48(2): 149-155.

相关文章 15

[1]	孔昕欣,孙书珍,李倩,陈元,周爱华,王莉,姚秀俊. 抗H因子抗体阳性溶血尿毒综合征7例分析[J]. 山东大学学报 (医学版), 2022, 60(4): 82-86.
[2]	孙继业,王紫欧,孙晓伟,李洪涛. 中药熏蒸联合体外冲击波对72例髋关节撞击综合征临床疗效、血清炎症因子水平的影响[J]. 山东大学学报 (医学版), 2022, 60(4): 76-81.
[3]	王艳莉,冯晔,周秀耕,杨跃,吴楠,方玉,阎石,李少雷,吕超,韩超,杜松涛. 33例食管癌患者围术期补充乳清蛋白粉对术后并发症的预防作用[J]. 山东大学学报 (医学版), 2022, 60(3): 64-70.
[4]	李青,林雪艳,刘天航,李晓文,范明喆,赵瑞瑞,田永杰. 经阴道网片盆底重建术的疗效中长期随访[J]. 山东大学学报 (医学版), 2022, 60(3): 71-75.
[5]	林均馨,刘玉江,刘培来,万连平,张鹏,杜建春,刘泽淼,孔杰,高升焘. 固定平台单髁术后胫骨假体周围骨折2例[J]. 山东大学学报 (医学版), 2022, 60(3): 96-99.
[6]	王喆,刘玉洁,毛倩,管佩霞,包绮晗,李承圣,乔晓伟,潘庆忠,王素珍. 基于逆概率加权法的早期三阴性乳腺癌不同治疗方案的疗效评价[J]. 山东大学学报 (医学版), 2021, 59(8): 113-118.
[7]	邹俊逸,张辉,张歆杰,李子佳,许明雷,王东. 110例原位心脏移植临床经验[J]. 山东大学学报 (医学版), 2021, 59(8): 86-91.
[8]	张建平,罗莺儿. 抗凝药物在反复不良妊娠治疗中的应用进展[J]. 山东大学学报 (医学版), 2021, 59(8): 14-19.
[9]	苗壮,刘培来,卢群山,姚天笑,李松林,罗德素. 双柱活动型单髁假体治疗膝关节内侧骨关节炎的早期疗效分析[J]. 山东大学学报 (医学版), 2021, 59(5): 90-95.
[10]	郭志华,赵大庆,邢园,王薇,梁乐平,杨静,赵倩倩. Ⅰ期端端吻合术治疗重度颈段气管狭窄临床分析[J]. 山东大学学报 (医学版), 2020, 1(7): 72-76.
[11]	程瑞林,黄政,李正勋,张宁,胡勇,徐文鹏. 小切口腓肠肌腱翻瓣术治疗5例陈旧性跟腱断裂[J]. 山东大学学报 (医学版), 2020, 58(6): 92-96.
[12]	阚娜娜,余丽春,孙书珍,李倩,栾春丽. 儿童肾病综合征型狼疮性肾炎30例临床、病理及近期疗效观察[J]. 山东大学学报 (医学版), 2020, 58(2): 54-59.
[13]	王彬,布学慧,孔祥亘,张照华,吴谙诏,肖迪,蒋雪梅. 成人37例与儿童10例新型冠状病毒肺炎的临床特点比较[J]. 山东大学学报 (医学版), 2020, 58(10): 112-116.
[14]	张国英,王静,王传霞,张玄,迟翔宇,李青. 经鼻高流量湿化氧疗对急性心源性肺水肿患者的临床疗效[J]. 山东大学学报 (医学版), 2020, 58(1): 77-80.
[15]	王化生, 欧仁杰,王默,白龙振,李英杰,孙超,王永梅. 隐源性机化性肺炎9例并文献复习[J]. 山东大学学报 (医学版), 2020, 58(1): 81-86.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed